Drug firm Lupin on Thursday said it has received USD 25 million (around Rs 205 crore) from AbbVie Inc for meeting a key development milestone for a product to treat hematological cancers.
The two sources said the syrup was made with industrial-grade PG, a toxic material widely used in liquid detergents, antifreeze, paints or coatings, and to enhance the effectiveness of pesticides
Shilpa Medicare fell 3.62% to Rs 498.35 after the company s consolidated net profit slumped 77.35% to Rs 7.83 crore on 5.44% decrease in revenue from operations to Rs 208.03 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax tanked 79.79% to Rs 8.40 crore in Q4 FY21 as against Rs 41.57 crore in Q4 FY20. The Q4 earnings was declared at the fag end of market hours yesterday, 31 May 2021.
EBITDA skid 39% to Rs 33.12 crore in Q4 FY21 as against Rs 54.50 crore over the same period last year. EBITDA margin stood at 15% in Q4 March 2021 from 24% in Q4 March 2020.
During the financial year, Shilpa Medicare s consolidated net profit declined 5.36% to Rs 147.78 crore on 0.75% slip in revenue from operations to Rs 901.13 crore in FY 2021 over FY 2020.